Advertisement

Psychopharmacology

, Volume 182, Issue 1, pp 45–53 | Cite as

Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms

  • Maria M. Campos
  • Elizabeth S. Fernandes
  • Juliano Ferreira
  • Adair R. S. Santos
  • João B. Calixto
Original Investigation

Abstract

Rationale

Currently available therapy for depression treatment is often associated with several undesirable side effects, and it is effective only in a certain portion of the population. Therefore, the identification of alternative therapeutic tools for the treatment of depression is still needed.

Objective

The present study analyzed the possible antidepressant-like effects of the Brazilian medicinal plant, Trichilia catigua, in rodents. Attempts were also made to investigate some of the possible mechanisms implicated in its actions.

Methods

The antidepressant-like effects of T. catigua extract were assessed in two species of rodents (mice and rats) by means of in vivo (forced swimming test) and in vitro (monoamine reuptake and release in synaptosomal preparations) approaches.

Results

Acute oral treatment with the extract of T. catigua produced antidepressant-like effects in the forced swimming model in both mice and rats. Anti-immobility actions of T. catigua extract in mice were significantly reversed by haloperidol or by chlorpromazine, but not by pimozide, ketanserin, spiroxatrine or p-chlorophenylalanine. In vitro, T. catigua extract concentration-dependently inhibited the uptake and increased the release of serotonin, and especially of dopamine, from rat brain synaptosomal preparations.

Conclusions

The present study provides convincing evidence for a dopamine-mediated antidepressant-like effect of the active principle(s) present in the hydroalcoholic extract of T. catigua in mice and rats when in vivo and in vitro strategies were employed. Therefore, a standardized T. catigua extract or its purified constituents could be of potential interest for the treatment of depressive disorders.

Keywords

Trichilia catigua Catuaba Antidepressant Mice Rat Monoamine uptake and release 

Notes

Acknowledgements

This work was supported by grants from CNPq, CAPES, PRONEX and Laboratório Catarinense (Brazil). E.S.F and J.F. are Ph.D. students receiving grants from CAPES and CNPq, respectively. M.M.C. holds a postdoctoral fellowship from CAPES. The technical assistance of Ms. Aline Mariana Venâncio is gratefully acknowledged.

References

  1. Antunes E, Gordo WM, de Oliveira JF, Teixeira CE, Hyslop S, De Nucci G (2001) The relaxation of isolated rabbit corpus cavernosum by the herbal medicine Catuama and its constituents. Phytother Res 15:416–421CrossRefPubMedGoogle Scholar
  2. Bennett BA, Paris JM, Pecora JR (1993) Stimulant-induced alterations in dopaminergic and serotonergic function in fetal raphe neurons. Brain Res Bull 31:471–476CrossRefPubMedGoogle Scholar
  3. Bosker FJ, Westernik BH, Cremers TI, Gerrits M, Van Der Hart MG, Kuipers SD, Van Der Pompé G, Ter Horst GJ, Den Boer JA, Korf J (2004) Future antidepressants: what is in the pipeline and what is missing? CNS Drugs 18:705–732PubMedCrossRefGoogle Scholar
  4. Cabrini DA, Calixto JB (1997) Herbal Catuama induces endothelium-dependent and -independent vasorelaxation action on isolated vessels from rats, guinea-pigs and rabbits. Phytother Res 11:32–38CrossRefGoogle Scholar
  5. Campos MM, Fernandes ES, Ferreira J, Bortolanza LB, Santos AR, Calixto JB (2004) Pharmacological and neurochemical evidence for antidepressant-like effects of the herbal product Catuama. Pharmacol Biochem Behav 78:757–764CrossRefPubMedGoogle Scholar
  6. Chatterjee SS, Bhattacharya SK, Wonnemann M, Singer A, Muller WE (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 63:499–510CrossRefPubMedGoogle Scholar
  7. D'Aquila PS, Collu M, Gessa GL, Serra G (2000) The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405:365–373CrossRefPubMedGoogle Scholar
  8. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotoninergic and noradrenergic antidepressants. Psychopharmacology 121:66–72PubMedCrossRefGoogle Scholar
  9. Erfurth A, Michael N, Stadtland C, Arolt V (2002) Bupropion as add-on strategy in difficult-to-treat bipolar depressive patients. Neuropsychobiology 45(Suppl 1):33–36CrossRefPubMedGoogle Scholar
  10. Feighner JP (1999) Mechanism of action of antidepressant medications. J Clin Psychiatry 60(Suppl 4):4–11PubMedGoogle Scholar
  11. Gavioli EC, Vaughan CW, Marzola G, Guerrini R, Mitchell VA, Zucchini S, De Lima TCM, Rae GA, Salvadori S, Regoli D, Calo G (2004) Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice. Naunyn Schmiedeberg's Arch Pharmacol 369:547–553CrossRefGoogle Scholar
  12. Holland HC, Weldon E (1968) A note on a new technique of recording ambulation in the open field test and its validation. Acta Psychol (Amst) 28:293–300CrossRefGoogle Scholar
  13. Jorenby D (2002) Clinical efficacy of bupropion in the management of smoking cessation. Drugs 62(Suppl 2):25–35PubMedCrossRefGoogle Scholar
  14. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523–532PubMedCrossRefGoogle Scholar
  15. Luscombe GP, Martin KF, Hutchins LJ, Gosden J, Heal DJ (1993) Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by post-synaptic 5-HT1A receptors. Br J Pharmacol 108:669–677PubMedGoogle Scholar
  16. Müller WE (2003) Current St. John's wort research from mode of action to clinical efficacy. Pharmacol Res 47:101–109CrossRefPubMedGoogle Scholar
  17. Nakamura K, Tanaka Y (2001) Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology 158:205–212CrossRefPubMedGoogle Scholar
  18. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999) Serotoninergic mediation of the effects of fluoxetine, but not desipramine in the rat forced swimming test. Psychopharmacology 147:162–167CrossRefPubMedGoogle Scholar
  19. Pania L, Gessab GL (2002) Dopaminergic deficit and mood disorders. Int Clin Psychopharmacol 17(Suppl 4):1–7PubMedGoogle Scholar
  20. PetitDemouliere B, Chenu F, Bourin M (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177:245–255CrossRefPubMedGoogle Scholar
  21. Pizzolatti MG, Verdi LG, Brighente IM, Madureira LA, Braz Filho R (2002) Minor gamma-lactones from Trichilia catigua (Meliaceae) and its precursors by GC-MS. Nat Prod Res 18:433–438CrossRefGoogle Scholar
  22. Pizzolatti MG, Venson AF, Smania A Jr, Smania Ede F, Braz-Filho R (2004) Two epimeric flavalignans from Trichilia catigua (Meliaceae) with antimicrobial activity. Z Naturforsch 57:483–488Google Scholar
  23. Porsolt RD, Bertin A, Jalfre M (1977a) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336PubMedGoogle Scholar
  24. Porsolt RD, Le Pichon M, Jafre M (1977b) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732CrossRefPubMedGoogle Scholar
  25. Porsolt RD, Bertin A, Blavet N, Jalfre M (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391CrossRefPubMedGoogle Scholar
  26. Rodrigues AL, da Silva GLO, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA, Calixto JB, Santos ARS (2002) Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 70:1347–1358CrossRefPubMedGoogle Scholar
  27. Russig H, Spooren W, Durkin S, Feldon J, Yee BK (2004) Apomorphine-induced disruption of prepulse inhibition that can be normalized by systemic haloperidol is insensitive to clozapine pretreatment. Psychopharmacology 175:143–147CrossRefPubMedGoogle Scholar
  28. Saddi G, Abbott FV (2000) The formalin test in the mouse: a parametric analysis of scoring properties. Pain 89:53–63PubMedCrossRefGoogle Scholar
  29. Skolnick P (2002) Beyond monoamine-based therapies: clues to new approaches. J Clin Psychiatry 63:19–23PubMedGoogle Scholar
  30. Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS (2003) “Broad spectrum” antidepressants: is more better for the treatment of depression? Life Sci 73:3175–3179CrossRefPubMedGoogle Scholar
  31. Stahl SM (1998) Basic psychopharmacology of antidepressants: Part 1. Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59(Suppl 4):5–14PubMedGoogle Scholar
  32. Vaz RV, Mata LV, Calixto JB (1997) Analgesic effect of the herbal medicine Catuama in thermal and chemical models of nociception in mice. Phytother Res 11:101–106CrossRefGoogle Scholar
  33. Wiley JL, Martin BR (2003) Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471:185–193CrossRefPubMedGoogle Scholar
  34. Yamada J, Sugimoto Y, Yamada S (2004) Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 504:207–211CrossRefPubMedGoogle Scholar
  35. Yoshitake T, Iizuka R, Yoshitake S, Weikop P, Muller WE, Ogren SO, Kehr J (2004) Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 42:414–418CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Maria M. Campos
    • 1
  • Elizabeth S. Fernandes
    • 1
  • Juliano Ferreira
    • 1
  • Adair R. S. Santos
    • 2
  • João B. Calixto
    • 1
  1. 1.Department of Pharmacology, Center of Biological SciencesUniversidade Federal de Santa CatarinaFlorianópolisBrazil
  2. 2.Department of Physiology, Center of Biological SciencesUniversidade Federal de Santa CatarinaFlorianópolisBrazil

Personalised recommendations